|
[1]
|
https://pubchem.ncbi.nlm.nih.gov/compound/niclosamide
|
|
[2]
|
国家药典委员会. 中华人民共和国药典[M]. 第一部. 北京: 中国医药科技出版社, 2015: 248.
|
|
[3]
|
Cartwright, A.C. (2016) The British Pharmacopoeia, 1864 to 2014. Isis, Vol. 107. [Google Scholar] [CrossRef]
|
|
[4]
|
European Pharmacopoeia Commission (2019) European Pharmacopoeia. 10th Edition, European Directorate for Quality Medicines, Strasbourg, 68-97.
|
|
[5]
|
WHO (2020) The International Pharmacopoeia (Ph.Int.)-Radi Pharmareutirals.
https://digicollections.net/phint/2020/index.html#d/b.6.1.248
|
|
[6]
|
Sail, V. and Hadden, M.K. (2012) Chapter Eighteen. Notch Pathway Modulators as Anticancer Chemotherapeutics. In: Annual Reports in Medicinal Chemistry, Vol. 47, Elsevier, Amsterdam, 267-280. [Google Scholar] [CrossRef]
|
|
[7]
|
Gönnert, R. and Scluaufstätter, E. (1958) A New Molluscicide: Molluscicide Bayer 73. Proceedings 6th International Congress for Tropical Medicine Malaria, Lisbon, Vol. 2, 197-202.
|
|
[8]
|
Schraufstaetter, E. and Goennert, R. (1959) Gastropoden-Bekaempfungsmittel. DE1024745, 1958; Gastropod Combating Composition. GB824345.
|
|
[9]
|
Schraufstatter, E. and Gonnert, R. (1963) Method of Combating Gastropods. US3079297.
|
|
[10]
|
Scluaufstätter, E. and Gönnert, R. (1964) Gastropod Combating Salicylanilides. US3147300.
|
|
[11]
|
Bekhli, A.F., et al. (1965) Synthesis of Phenasal. Meditsinskaia promyshlennost’SSSR, 19, 25-27. (In Russian)
|
|
[12]
|
Florey, K. (2005) Profiles of Drug Substances, Excipients and Related Methodology. Academic Press, Cambridge, Vol. 32, 67-96.
|
|
[13]
|
Kar, A. (2004) Advanced Practical Medicinal Chemistry/Theory Methodology Purification Usages. New Age International (P) Ltd., New Delhi, 281.
|
|
[14]
|
陈循军, 尹国强, 崔英德. 氯硝柳胺的合成工艺研究[J]. 精细石油化工进展, 2005, 6(7): 47-49.
|
|
[15]
|
Strufe, R., Scluaufstätter, E. and Gönnert, R. (1963) Alkanolamine Salts of Salicyl Anilides and Process for Their Production. US3113067.
|
|
[16]
|
Doan, T.L., et al. (2011) Chap. 23. The Future of Drug Repositioning: Old Drugs, New Opportunities. In: Macor, J.E., Ed., Annual Reports in Medicinal Chemistry (Book Series), Vol. 46, Elsevier Inc., Amsterdam, 385-401. [Google Scholar] [CrossRef]
|
|
[17]
|
Thayer, A.M. (2012) Drug Repurposing. Chemical & Engineering News, 90, 15-25. [Google Scholar] [CrossRef]
|
|
[18]
|
Chong, C.R. and Sullivan Jr., D.J. (2007) New Uses for Old Drugs. Nature, 448, 645-646. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Ashburn, T. and Thor, K. (2004) Drug Repositioning: Identifying and Developing New Uses for Existing Drugs. Nature Reviews Drug Discovery, 3, 673-683. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Chisholm, K.M., Chang, K.W., Truong, M.T., Kwok, S., West, R.B. and Heerema-McKenney, A.E. (2012) β-Adrenergic Receptor Expression in Vascular Tumors. Modern Pathology, 25, 1446-1451. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Drug Repurposing. https://cdcn.org/repurpose
|
|
[22]
|
Barratt, M.J. and Frail, D.E. (2012) Drug Repositioning: Bringing New Life to Shelved Assets and Existing Drugs. John Wiley & Sons, Hoboken. [Google Scholar] [CrossRef]
|
|
[23]
|
Persidis, A. (2015) Myths and Realities of Repositioning. Arrowhead 4th Annual Drug Repositioning, Repurposing & Rescue Conference, Chicago, 27-28 May 2015.
|
|
[24]
|
Graul, A.I., Sorbera, L., Pina, P., et al. (2010) The Year’s New Drugs & Biologics—2009. Drug News & Perspectives, 23, 7-36. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
BCC Research (2016, January) Global Markets for Drug Repurposing.
https://www.bccresearch.com/market-research/pharmaceuticals/drug-repurposing-markets-report.html
|
|
[26]
|
Zhao, K. and So, H.-C. (2019) Using Drug Expression Profiles and Machine Learning Approach for Drug Repurposing. In: Methods in Molecular Biology (Book Series), Vol. 1903, Springer, Berlin, 219-237. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Saraswathy, G.R., et al. (2020) Chapter 4. Unveiling Potential Anticancer Drugs through in Silico Drug Repurposing Approaches. In: To, K.K.W. and Cho, W.C.S., Eds., Drug Repurposing in Cancer Therapy: Approaches and Applications, Elsevier Inc., Amsterdam, 81-119. [Google Scholar] [CrossRef]
|
|
[28]
|
Vanhaelen, Q. (2019) Computational Methods for Drug Repurposing. Springer Science, Berlin. [Google Scholar] [CrossRef]
|
|
[29]
|
Jarada, T.N., Rokne, J.G. and Alhajj, R. (2021) SNF-NN: Computational Method to Predict Drug-Disease Interactions Using Similarity Network Fusion and Neural Networks. BMC Bioinformatics, 22, Article No. 28. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Scheffler, B., Glas, M. and Wieland, A. (2017) Niclosamide and Its Derivatives for Use in the Treatment of Solid Tumors. US 9,844,522.
|
|
[31]
|
Jourdan, J.-P., Bureau, R., Rochais, C. and Dallemagne, P. (2020) Drug Repositioning: A Brief Overview. Journal of Pharmacy and Pharmacology, 72, 1145-1151. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
张伦. 阿司匹林国内外的应用、生产和市场[J]. 化工时刊, 1997, 11(4): 29-32.
|
|
[33]
|
数据: 全球每年被吃掉1500亿片阿司匹林为何用量这么大? [EB/OL].
http://www.mnjkw.cn/yaopin/1913181.html, 2018-01-02.
|
|
[34]
|
轩秀晨, 黄卉, 吕桂香. 氯硝柳胺的药理学作用及机制研究进展[J]. 医学综述, 2021, 27(15): 3055-3060.
|
|
[35]
|
Chen, W., Mook Jr., R.A., Premont, R.T., et al. (2018) Niclosamide: Beyond an Anthelmintic Drug. Cellular Signalling, 41, 89-96. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Niclosamide—A Drug for More than One Purpose.
https://www.niclosamide.org/niclosamide-a-drug-for-more-than-one-purpose
|
|
[37]
|
Barbosa, E.J., Lobenberg, R., de Araujo, G.L.B., et al. (2019) Niclosamide Repositioning for Treating Cancer: Challenges and Nano-Based Drug Delivery Opportunities. European Journal of Pharmaceutics and Biopharmaceutics, 141, 58-69. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Chan, M.M., Chen, R. and Fong, D. (2018) Targeting Cancer Stem Cells with Dietary Phytochemical—Repositioned Drug Combinations. Cancer Letters, 433, 53-64. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Li, Y.H., Li, P.K., Roberts, M.J., et al. (2014) Multi-Targeted Therapy of Cancer by Niclosamide: A New Application for an Old Drug. Cancer Letters, 349, 8-14. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Pantziarka, P., Sukhtame, V., Meheus, L., et al. (2017) Repurposing Non-Cancer Drugs in Oncology—How Many Drugs Are out There? [Google Scholar] [CrossRef]
|
|
[41]
|
Braga, L., Ali, H., Secco, I., et al. (2021) Drugs That Inhibit TMEM16 Proteins Block SARS-CoV-2 Spike-Induced Syncytia. Nature, 594, 88-93. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Yu, S., Piao, H., Rejinold, N.S., et al. (2021) Niclosamide-Clay Intercalate Coated with Nonionic Polymer for Enhanced Bioavailability toward COVID-19 Treatment. Polymers (Basel), 13, 1044. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Al-kuraishy, H.M., Al-Gareeb, A.I., Alzahrani, K.J., et al. (2021) Niclosamide for Covid-19: Bridging the Gap. Molecular Biology Reports, 48, 8195-8202. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Triggle, D.J. (2006) Comprehensive Medicinal Chemistry II, Vol. 8, Sets. Elsevier, Amsterdam, Vol. 7, 273.
|
|
[45]
|
Marrugal-Lorenzo, J.A., Serna-Gallego, A., Berastegui-Cabrera, J., et al. (2019) Repositioning Salicylanilide Anthelmintic Drugs to Treat Adenovirus Infections. Scientific Reports, 9, Article No. 17.
https://www.nature.com/scientificreports [Google Scholar] [CrossRef] [PubMed]
|